1. Home
  2. Nation
  3. Centre says Cough syrup linked to death in Gambia is not sold in India

Centre says Cough syrup linked to death in Gambia is not sold in India

WHO Alert On Indian Cold And Cough Syrup: IMA said that WHO should give all the evidence so that the conclusion can be reached, because it is a question of prestige of the country.

By Ruchi Upadhyay 
Updated Date

New Delhi: On Wednesday (October 5), the World Health Organization (WHO) has issued an alert regarding a pharmaceutical company in India. After the death of 66 children in Gambia, WHO says that four cold and cough syrups made in India can be fatal for children. These syrups are made by Maiden Pharmaceuticals Limited Company of India. After this investigation has been started against the company.

Also Read :- SC stays Andhra HC's order to develop Amaravati as state capital in 6 month

According to WHO, the same pattern was revealed in the deaths of these 66 children. All of them were below 5 years of age, who were falling ill after 3 to 5 days of taking the cough syrup. Along with this, it was told that the quantity of Diethylene Glycol and Ethylene Glycol in all the four cough syrups has been found to be more than the prescribed quantity. On this, ABP News from the company tried to know his side by going to his Pitampura office, but the office was closed.

National President of Indian Medical Association (IMA) Dr. Sahajanand Prasad Singh said that the entire matter should be investigated. Whenever India sent medicines to any other country, it would be checked, then it would also have to be seen whether any other medicine was sent along with cough syrup. WHO should give all the evidence so that conclusion can be reached, because it is a question of prestige of the country. At the same time, sources in the Indian Ministry of Health and Drug Controller General of India (DGCI) say that investigation is being done.

Haryana Health Minister Anil Vij said that samples of four types of cough syrups produced by the company have been sent to the Central Pharmaceutical Laboratory (CDAL) in Kolkata. “The samples were collected by DCGI and Food and Drugs Administration Department of Haryana and sent to CDL, Kolkata,” he said. health).

The cough syrup produced by the company was approved for export and is not available for sale in the country. Whatever steps have to be taken, it will be taken after the report of CDL.

Also Read :- Delhi air quality remains in 'very poor' category ; minimum temperature dips to 7.6°C

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...